Biosimilars
- All
- Analytical Services
- Bioanalytical Services
- Bioassay Development
- Biologics, Proteins, Vaccines
- Biosimilars
- Chemistry
- Clinical Trials
- Drug Delivery
- Drug Development
- Drug Discovery
- Formulation Development
- Information Technology
- Laboratory Testing
- Methods Development
- Microbiology
- Preclinical Outsourcing
- R&D
- Toxicology
-
Biosimilars
The U.S. Biosimilars Market: Shaking the “Laggard” Label
Biosimilar uptake set to reshape the U.S. marketKatya Svoboda and Bob Swann, ICON 05.05.20
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, DKSH Partner to Bring Biosimilar to Asia
Biosimilar of AbbVie’s Humira to be developed and supplied by Alvotech03.26.20
-
Biosimilars
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, JAMP Pharma Ink Biosim Deal
Enter into an exclusive partnership for the commercialization of key biosimilars in Canada.01.15.20
-
Biologics, Proteins, Vaccines | Biosimilars
Biopharma Over 20 Years
A look at the key trends that have impacted the biopharma industry over the years.K. John Morrow, Jr. and Eric S. Langer, BioPlan Associates 11.20.19
-
Biologics, Proteins, Vaccines | Biosimilars
Europe to Surpass U.S. Biologic Manufacturing Capacity by 2023
CPhI Annual Report says demand for biological manufacturing is growing faster than capacity growth.Online Exclusives11.04.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
Horizon, Glenmark Sign Biomfg. License Agreement
For GS knockout CHO cell line for manufacture of biotherapeutics09.30.19
-
Biosimilars
The Bioprocessing Trek
Biosimilars are the next speed-bump for CMOsEmil W. Ciurczak, DoraMaxx Consulting 09.16.19
-
Bio News | Biosimilars | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News
Lonza, Celltrion Sign Contract to Manufacture Remsima Drug Substance
Lonza’s biologics facility in Singapore to cover EU and U.S. market needs09.03.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Alvotech, Prestige Biopharma Enter New Manufacturing Partnership
Alvotech Contract Services to make one of Prestige’s biosimilar candidates08.28.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Alvotech, Cipla Gulf Ink Biosimilar Deal
Will partner for the commercialization of key biosimilar in select emerging markets07.29.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News | Collaborations & Alliances | Facilities | Industry News
Celltrion, Nan Fung Group Set Up Bio CDMO in China
Establish Vcell Healthcare to develop and commercialize biosimilars; will open biologics manufacturing facility07.19.19
-
Biologics, Proteins, Vaccines | Biosimilars
Biotech Booms in the Yangtze River Valley
A look at forces shaping the course of biotech growth in ChinaDaniel Burch, M.D., Global Medical Officer, PPD Biotech 05.07.19
-
Biologics, Proteins, Vaccines | Biosimilars
Are Biotech Companies Strong Investments?
Biotech capital raised via IPO has increased dramatically over the past couple of years.Jason Monteleone , CEO, Clinipace 05.07.19
-
Bio News | Biologics, Proteins, Vaccines | Biosimilars | Breaking News
BioPlan Benchmarks the State of Biopharma Mfg.
Participate in the 16th Annual Biopharma Survey Report!03.08.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Drug Development | Industry News
Selexis, Turgut Expand Biosimilar Development Pact
Under new commercial license agreements, Selexis will help advance Turgut’s pipeline of biosim products in oncology02.28.19
-
Bio News | Biosimilars | Breaking News
Samsung Bioepis, C-Bridge Capital to Develop Next-Gen Biosims in China
C-Bridge forms new biopharmaceutical company, AffaMed Therapeutics, which will collaborate with Samsung Bioepis02.11.19
-
Bio News | Biosimilars | Breaking News | Industry News
Alvotech Raises $300M to Fuel Biosimilar Growth
Current pipeline consists of six biosimilar monoclonal antibodies aimed at treating cancer, autoimmune, inflammatory and other diseases01.22.19
-
Bio News | Biosimilars | Breaking News | Collaborations & Alliances | Industry News
Sandoz Enters Biosimilars Deal with Gan & Lee Pharmaceutical in China
Covers biosimilar insulins in early and clinical development for the top three selling branded insulins by sales: glargine, lispro and aspart12.28.18
-
Biosimilars | Breaking News | Drug Development | Industry News
Alvotech, Fuji Pharma Expand Biosimilars Alliance
Fuji invests $50 million in Alvotech, expands development and commercialization of biosimilars in Japan12.18.18
